Skip to main content
OpenTrials
Completed

NCT Number: NCT01275495

Telephone Assessment and Skill-Building Intervention for Stroke Caregivers

The purpose of this study is to test the efficacy of the revised Telephone Assessment and Skill-Building Kit (TASK II) compared with an Information, Support, and Referral (ISR) intervention in family caregivers of stroke survivors. We will also test if TASK II intervention effects on primary outcomes (depressive symptoms, caregiving-related negative life changes, unhealthy days) are mediated through effects on secondary outcomes (task difficulty, optimism, threat appraisal). Comparative costs and outcomes for the TASK II and ISR interventions will also be explored.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Indiana University School of Nursing

Indianapolis, Indiana, 46202, United States

About this study

Stroke is the number one cause of disability in the United States, and over 4 million stroke survivors are alive today. Many stroke survivors need the help of a family caregiver. A family caregiver is a family member or close friend who helps the stroke survivor once they go home. Many caregivers need information and support during the first few months after the stroke survivor is discharged home. One group of caregivers will receive the TASK II intervention and another group of caregivers will receive existing educational materials about stroke and caregiving through an information, support, and referral (ISR) process. Both groups of caregivers will receive written materials about stroke and caregiving by mail and weekly telephone calls by a nurse for a total of 8 weeks, with an additional call at 12 weeks. A research assistant will also call by telephone at the beginning of the study, and at 8, 12, and 24 weeks after the beginning of the study, with a follow-up call at 1 year to interview both groups of caregivers about their caregiving activities and about their own health and well-being. If shown to be efficacious, our next goal will be to translate the TASK II intervention into practice settings to meet current recommendations and guidelines that emphasize follow up care for stroke survivors and their family caregivers.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Primary caregiver (unpaid family member or significant other) of a stroke survivor
  • No more than 8 weeks after survivor discharged home
  • Plans to be providing care for 1 year or longer
  • Access to a telephone
  • Willingness to participate in 9 calls from a nurse and 5 data collection interviews at designated study time points

Exclusion criteria

  • Caregiver or survivor age < 21 years
  • Caregiver denies that survivor has had a stroke
  • Caregiver does not consider him or herself a caregiver, stating that the survivor is not impaired or is the same as before the stroke
  • Caregiver has low task difficulty (OCBS task difficulty score < 16)
  • Caregiver communication difficulties (e.g., hearing loss)
  • Caregiver not fluent in the English language
  • Caregiver 6-item MMSE score less than 4
  • Survivor residing in a nursing home or long-term care facility
  • Survivor or caregiver has a terminal illness (e.g., cancer, end of life condition with decreased life expectancy, renal failure requiring dialysis)
  • Survivor or caregiver history of hospitalization for alcohol or drug abuse
  • Survivor or caregiver history of severe mental illness (e.g., Alzheimer's, dementia, suicidal tendencies, severe untreated depression or manic depressive disorder, schizophrenia)
  • Survivor or caregiver pregnancy
  • Survivor or caregiver is a prisoner or on house arrest

Treatment and study plan

Telephone Assessment and Skill-Building Kit (TASK II)

Behavioral

Information, Support, and Referral (ISR)

Behavioral

Primary outcomes

  1. Depressive symptoms: Patient Health Questionnaire Depression Scale (PHQ-9)

    Time frame: Change in depressive symptoms from baseline to 8 weeks

    Among caregivers who screen positive for depressive symptoms at baseline, those randomized to the TASK II intervention will have a greater reduction in depressive symptoms compared to those randomized to the ISR group from baseline to 8 weeks, after controlling for selected covariates. Long-term, sustained efficacy will be assessed at 12 and 24 weeks, and at 1 year.

  2. Caregiving-related negative life changes: Bakas Caregiving Outcomes Scale (BCOS)

    Time frame: Change in caregiving-related negative life changes from baseline to 8 weeks

    Caregivers randomized to the TASK II group will have a greater reduction in caregiving-related negative life changes compared with those randomized to the ISR group from baseline to 8 weeks, after controlling for selected covariates. Long-term, sustained efficacy will be assessed at 12 and 24 weeks, and at 1 year.

  3. Unhealthy days: Unhealthy Days (UD)

    Time frame: Change in unhealthy days from baseline to 8 weeks

    Caregivers randomized to the TASK II group will have a greater reduction in unhealthy days compared with those randomized to the ISR group from baseline to 8 weeks, after controlling for selected covariates. Long-term, sustained efficacy will be assessed at 12 and 24 weeks, and at 1 year.

Secondary outcomes

  1. Task difficulty: Oberst Caregiving Burden Scale Difficulty Subscale (OCBS)

    Time frame: Change in task difficulty from baseline to 8 weeks

    Caregivers randomized to the TASK II group will have a greater reduction in task difficulty compared with those randomized to the ISR group from baseline to 8 weeks, after controlling for selected covariates. Long-term, sustained efficacy will be assessed at 12 and 24 weeks, and at 1 year.

  2. Optimism: Revised Life Orientation Test (LOT-R)

    Time frame: Change in optimism from baseline to 8 weeks

    Caregivers randomized to the TASK II group will have a greater increase in optimism compared with those randomized to the ISR group from baseline to 8 weeks, after controlling for selected covariates. Long-term, sustained efficacy will be assessed at 12 and 24 weeks, and at 1 year.

  3. Threat appraisal: Appraisal of Caregiving Threat Subscale (ACS)

    Time frame: Change in threat appraisal from baseline to 8 weeks

    Caregivers randomized to the TASK II group will have a greater reduction in threat appraisal compared with those randomized to the ISR group from baseline to 8 weeks, after controlling for selected covariates. Long-term, sustained efficacy will be assessed at 12 and 24 weeks, and at 1 year.

Sponsors and collaborators

Lead sponsor

Indiana University

Other

Collaborators

  • National Institute of Nursing Research (NINR)

Registry information

Acronym: TASKII

Important dates

Study start
2010
Primary completion
2014
Study completion
2014
First posted
Jan 12, 2011
Registry last updated
Mar 31, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.